Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A

NCT02280265 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Recombinant Human Coagulation Factor VIII for injection

Sponsor

Nanjing Medical University